Europe Approves High-Price Gene Therapy

Published November 11, 2012

Europe approves high-price gene therapy

Filed under: drug treatment news 2012

LONDON | Fri Nov 2, 2012 7:59am EDT. LONDON (Reuters) – European officials have approved the Western world's first gene therapy drug from a small Dutch biotech company, in a milestone for the novel medical technology that fixes faulty genes.
Read more on Reuters

Novartis Cannibalizes Gleevec to Boost New Cancer Drug

Filed under: drug treatment news 2012

… to Boost New Cancer Drug. By Eva von Schaper on October 25, 2012 … The Swiss company revolutionized leukemia treatment with Gleevec, a drug that turned a deadly blood cancer into a chronic disease more than a decade ago. Many doctors have since …
Read more on Businessweek

Novartis says may have 14 new blockbuster drugs by 2017

Filed under: drug treatment news 2012

ZURICH | Thu Nov 8, 2012 8:31am EST. ZURICH (Reuters) – Novartis could … Among its most promising products are serelaxin and LCZ686 to treat patients with heart failure as well as drugs for psoriasis and multiple sclerosis. It plans to file serelaxin …
Read more on Reuters